Cytek Biosciences, Inc.
NASDAQ: CTKB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Wenbin Jiang
- Employees
- 663
- Headquarters
- Fremont, United States
- IPO year
- 2021
- Market cap
- $552.7M
- Website
- https://cytekbio.com
Loading CTKB…
Loading profile data…Frequently asked questions about CTKB
What does Cytek Biosciences, Inc. (CTKB) do?
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluo...
Where does CTKB trade?
Cytek Biosciences, Inc. (CTKB) trades on the NASDAQ Global Select.
What sector is CTKB in?
Cytek Biosciences, Inc. (CTKB) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Cytek Biosciences, Inc.?
Wenbin Jiang is the chief executive officer of Cytek Biosciences, Inc. (CTKB).
Where is Cytek Biosciences, Inc. headquartered?
Cytek Biosciences, Inc. is headquartered in United States.
Does CTKB pay a dividend?
Cytek Biosciences, Inc. (CTKB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CTKB go public?
Cytek Biosciences, Inc. (CTKB) completed its initial public offering in 2021.